Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher ...

Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration. In the second part of her Q&A with The American Journal of Managed Care ®, Julie ...